Chief Financial Officer Shenouda Maged bought $1,100,000 worth of shares (500,000 units at $2.20), increasing direct ownership by 173% to 788,335 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RLMD· Relmada Therapeutics Inc.

Health Care

Original source

Chief Financial Officer Shenouda Maged bought $1,100,000 worth of shares (500,000 units at $2.20), increasing direct ownership by 173% to 788,335 units (SEC Form 4) | Quantisnow